Every Form 4 that IBEX Limited (IBEX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow IBEX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IBEX filings page.
IBEX Ltd (IBEX) reported that its Chief Operating Officer, David Martin Afdahl, sold common shares in an open-market transaction. On September 8, 2026, he sold 17,500 common shares at a weighted average price of $37.0862 per share, pursuant to a Rule 10b5-1 trading plan dated June 8, 2026. Following this sale, he directly owns 140,006 common shares of IBEX Ltd.
IBEX Ltd director Fiona Elizabeth Beck acquired 1,252 Common Shares on July 31, 2026 through performance-based stock units earned upon certification of performance goals for the period ending June 30, 2026. Following this award, she directly holds 14,835 Common Shares.
IBEX Ltd director Zhuang Mingzhe acquired 1,252 Common Shares on July 31, 2026 through the earning and conversion of performance-based stock units. These PSUs were earned when performance goals for the period ending June 30, 2026 were certified. After this equity award, Zhuang directly holds 8,335 Common Shares, reflecting compensation rather than an open-market purchase or sale.
IBEX Ltd director John William Jones acquired 1,353 Common Shares on July 31, 2026 at no cost, when previously granted performance-based stock units were earned upon certification of performance goals for the period ending June 30, 2026. After this conversion, he directly holds 16,597 Common Shares.
IBEX Ltd executive Bruce Neil Dawson, Chief Sales and CS Officer, earned and acquired 1,954 performance-based stock units that converted into Common shares on July 31, 2026 after performance for the period ending June 30, 2026 was certified. To satisfy related taxes, 855 shares were withheld by the company at $35.34 per share; no shares were sold by him to cover this tax liability.
IBEX Ltd reports that Chief Financial Officer Greenwald Taylor C acquired 3,307 Common Shares on July 31, 2026 when performance-based stock units were earned for the period ending June 30, 2026 and converted to stock. On the same date, 956 shares were withheld to satisfy tax liability at 35.3400 per share; no shares were sold into the market.
IBEX Ltd reports that Chief People Officer Paul Joseph Inson earned and acquired 2,405 Common Shares on July 31, 2026, when performance-based stock units were certified for the period ending June 30, 2026 and converted to shares. To cover related taxes, the issuer withheld 1,053 shares valued at $35.34 per share; no shares were sold into the market.
IBEX Ltd director Karen Batungbacal reported an equity compensation award. On July 31, 2026, 1,252 performance-based stock units (PSUs) were earned upon certification of performance goals for the period ending June 30, 2026 and converted into Common Shares, increasing her direct holdings to 8,335 shares.
IBEX Ltd director Patrick McGinnis reported an equity award. On July 31, 2026, he acquired 1,252 Common Shares when an equal number of performance-based stock units (PSUs) were earned after certification of performance goals for the period ending June 30, 2026 and converted into shares. Following this non-market award, he holds 7,085 Common Shares directly.
IBEX Ltd director Daniella Ballou-Aares reported the acquisition of 1,252 common shares on July 31, 2026. These shares were earned as performance-based stock units after certification of performance goals for the period ending June 30, 2026 and converted to common shares. Following this award, she holds 11,895 shares directly.
IBEX Ltd reported that Chief Sales/Marketing Officer Julie K. Casteel earned and acquired 2,646 performance-based stock units on July 31, 2026, upon certification of performance goals for the period ending June 30, 2026. These units converted into common shares, and 1,042 shares were withheld to cover tax liabilities at a closing price of $35.34 per share; no shares were sold.
IBEX Ltd reported that CEO Robert Thomas Dechant acquired 10,826 common shares on July 31, 2026, when performance-based stock units earned for the period ending June 30, 2026 were certified and converted to common shares. On the same date, 4,910 shares were withheld at $35.34 per share to cover his tax liability; no shares were sold.
IBEX Ltd reported equity compensation activity for Chief Legal Officer Christina Trofimuk-O'Connor. On July 31, 2026, she earned and acquired 2,646 performance-based stock units for the period ending June 30, 2026, which converted into Common shares. To cover taxes on this vesting, 950 shares were withheld at the $35.34 closing price, and no shares were sold on the open market.
IBEX Ltd reported that Chief Operating Officer David Martin Afdahl earned and acquired 2,646 performance-based stock units on July 31, 2026, upon certification of performance goals for the period ending June 30, 2026, which converted into Common Shares. On the same date, 1,304 shares were withheld to cover tax obligations at $35.34 per share.
Darwal Michael Joseph reported disposition transactions in this Form 4 filing.
IBEX Ltd reports that Chief AI & Digital Officer Michael Joseph Darwal transferred 200 Common Shares of IBEX on 2026-07-20 at $35.07 per share. A footnote states the shares were moved to a third party under a divorce-related legal agreement and do not represent a discretionary transaction. Darwal now directly holds 40,744 Common Shares.
IBEX Ltd Chief Financial Officer Taylor C. Greenwald reported a tax-related share withholding. On July 1, 2026, 853 common shares were withheld at $31.60 per share to cover tax liability tied to the vesting of 2,948 restricted stock units. The filing states no shares were sold in the market to satisfy this tax obligation, and Greenwald now holds 61,377 common shares directly.
IBEX Ltd Chief Executive Officer Robert Thomas Dechant reported a routine tax-withholding transaction related to equity compensation. On July 1, 2026, 4,511 Common Shares were withheld at $31.60 per share to cover taxes on the vesting of 9,946 restricted stock units. No shares were sold in the market, and Dechant's direct holdings after this withholding totaled 281,095 Common Shares.
IBEX Ltd Chief People Officer Paul Joseph Inson reported a tax-related share disposition. On July 1, 2026, 823 common shares were withheld by IBEX at $31.60 per share to cover tax owed when 1,880 restricted stock units vested. This withholding was done by the issuer as a net share settlement, and no shares were sold on the market to satisfy the tax liability. Following this transaction, Inson directly held 30,646 common shares, indicating the event was a routine compensation-related tax withholding rather than an open-market sale.
IBEX Ltd Chief AI & Digital Officer Michael Joseph Darwal reported a tax-related share withholding tied to restricted stock unit vesting. On July 1, 2026, 316 common shares were withheld at $31.60 per share to cover tax obligations when 880 restricted stock units vested. The filing notes that no shares were sold on the market to satisfy this tax liability, and Darwal now directly holds 40,944 common shares following the transaction.
IBEX Ltd Chief Sales/Marketing Officer Julie K. Casteel reported a routine tax-withholding share disposition linked to RSU vesting. On July 1, 2026, 910 common shares were withheld at $31.60 per share to cover taxes on 2,310 vested restricted stock units. The footnote states no shares were sold by Casteel to satisfy this tax liability. After the withholding, she directly holds 116,684 common shares.
IBEX Ltd Chief Operating Officer David Martin Afdahl reported a routine tax-related share disposition. On July 1, 2026, 1,138 common shares were withheld by IBEX to cover his tax liability from the vesting of 2,310 restricted stock units. The footnote clarifies that no shares were sold on the market to satisfy this obligation. After this withholding, Afdahl directly owned 156,164 IBEX common shares.
IBEX Ltd Chief Legal Officer Christina Alice Trofimuk-O'Connor reported a tax-related share disposition. On July 1, 2026, 700 common shares were withheld by IBEX at $31.60 per share to cover taxes on the vesting of 2,310 restricted stock units. According to the filing, no shares were sold to the market, and she now directly holds 35,035 common shares.
IBEX Ltd reported a routine insider transaction involving Chief Sales and CS Officer Bruce Neil Dawson. On July 1, 2026, 886 common shares were withheld by the company at $31.60 per share to cover tax obligations arising from the vesting of 2,022 restricted stock units. The footnote clarifies that no shares were sold in the market to satisfy this tax liability. After this tax-withholding disposition, Dawson directly holds 61,009 common shares.
IBEX Ltd reported an insider transaction by Chief Sales/Marketing Officer Julie K. Casteel. On June 11, 2026, she completed an open-market sale of 3,600 Common Shares at a weighted average price of $30.6065 per share. After this sale, she directly holds 117,594 Common Shares. The sale was executed in multiple trades, with individual prices ranging from $30.465 to $30.78, and the weighted average price aggregates those trades.
IBEX Ltd director Patrick McGinnis sold shares in a routine insider transaction. On May 28, 2026, he completed an open-market sale of 1,030 Common Shares at $31.69 per share. After this sale, he continues to hold 5,833 Common Shares directly.
IBEX Ltd Chief Financial Officer Taylor C. Greenwald reported two share transactions in Common Shares. On May 22, 2026, he sold 964 shares in an open-market sale at $32.02 per share and acquired 3,333 shares from earned performance-based stock units. After these transactions, he directly owned 62,230 Common Shares.
IBEX Ltd Chief Executive Officer Robert Thomas Dechant sold 7,800 common shares in an open-market transaction. The shares were sold at a weighted average price of $30.4996 per share, with individual trades executed between $30.37 and $30.88. After this sale, Dechant directly holds 285,606 IBEX common shares.
IBEX Ltd Chief Sales and CS Officer Bruce Neil Dawson reported two open-market sales of Common Shares. On May 11, 2026, he sold 3,129 shares at a weighted average price of $32.8038 per share. On May 12, 2026, he sold 15,260 shares at a weighted average price of $31.1156. After these transactions, he directly owns 61,895 Common Shares.
IBEX Ltd director Daniella Ballou-Aares reported selling 6,500 Common Shares in open-market transactions and now holds 10,643 shares directly. The sales included 5,843 shares at $24.2175 and 157 shares at $24.2114 on March 13, 2025, plus 500 shares at $35.01 on December 2, 2025.
Jones John William reported acquisition or exercise transactions in this Form 4 filing.
IBEX Ltd director John William Jones received an equity award of 2,250 common shares through restricted stock units. The RSUs carry a right to one common share each at no cash cost. The award vests 25% on July 1, 2026 and 25% annually for three additional years, contingent on his continued service. Following this grant, his direct ownership totals 15,244 common shares.
IBEX Ltd director Zhuang Mingzhe acquired 2,083 common shares through a stock award. The Form 4 shows a grant of restricted stock units (RSUs) at a price of $0.00 per share, increasing his direct holdings to 7,083 common shares.
The RSUs vest over four years. Twenty‑five percent vest on July 1, 2026, with an additional 25% vesting on each of the next three anniversaries, as long as he remains in continuous service on each vesting date.
Ballou-Aares Daniella reported acquisition or exercise transactions in this Form 4 filing.
IBEX Ltd director Daniella Ballou-Aares received an equity award of 2,083 common shares in the form of restricted stock units. The RSUs were granted at no cash cost and increase her direct holdings to 17,143 common shares. Twenty-five percent of the RSUs vest on July 1, 2026, with the remaining 75% vesting in equal annual installments over the following three years, contingent on her continued service.
McGinnis Patrick reported acquisition or exercise transactions in this Form 4 filing.
IBEX Ltd director Patrick McGinnis reported an equity award of 2,083 common shares in the form of restricted stock units (RSUs). The RSUs were granted at no cash price and increase his directly owned common shares to 6,863 after the transaction.
The footnote explains that each RSU represents a contingent right to receive one common share. Twenty-five percent of the RSUs vest on July 1, 2026, with the remaining 75% vesting in equal annual installments over the following three years, assuming he remains in continuous service on each vesting date.
Beck Fiona Elizabeth reported acquisition or exercise transactions in this Form 4 filing.
IBEX Ltd director Fiona Elizabeth Beck reported an equity award. She was granted 2,083 restricted stock units (RSUs), each representing a right to receive one common share at no cost. 25% of the RSUs vest on July 1, 2026, with the remaining 75% vesting in equal annual installments over the following three years, contingent on continued service. After this grant, her reported direct holdings total 13,583 common shares.
Batungbacal Karen reported acquisition or exercise transactions in this Form 4 filing.
IBEX Ltd director Karen Batungbacal reported an equity award of 2,083 common-share-based restricted stock units (RSUs). Each RSU represents the right to receive one common share. According to the vesting schedule, 25% of the RSUs vest on July 1, 2026, with an additional 25% vesting on each of the next three yearly anniversaries, as long as she remains in continuous service with the company.
Keen Shuja reported acquisition or exercise transactions in this Form 4 filing.
IBEX Ltd director Keen Shuja reported an equity award of 5,000 restricted stock units (RSUs). These RSUs give a contingent right to receive one common share for each unit. According to the grant terms, 25% of the RSUs vest on March 2, 2027, with an additional 25% vesting on the same date in each of the following three years, as long as Shuja remains in continuous service on each vesting date. The award was recorded at a price of $0.00 per share, reflecting that this is a compensation grant rather than an open-market purchase.
Dechant Robert Thomas reported acquisition or exercise transactions in this Form 4 filing.
IBEX Ltd reported that Chief Executive Officer Robert Thomas Dechant received an award of 18,000 Common Share–settled restricted stock units. These RSUs were granted at no cash cost and increase his directly held stake to 293,406 Common Shares, aligning his compensation further with shareholder interests.
According to the grant terms, 25% of the RSUs vest on July 1, 2026, with additional 25% installments vesting annually over the following three years, as long as he remains in continuous service. On each vesting date, IBEX will automatically withhold a portion of the resulting shares to cover tax withholding obligations in a non-discretionary transaction.
Greenwald Taylor C reported acquisition or exercise transactions in this Form 4 filing.
IBEX Ltd Chief Financial Officer Taylor C. Greenwald received a grant of 5,500 restricted stock units tied to IBEX common shares. Each RSU represents the right to receive one share. 25% vest on July 1, 2026, with additional 25% tranches vesting annually over the following three years, contingent on continued service. On each vesting date, IBEX will automatically withhold shares to cover tax obligations.
IBEX Ltd reported that Chief Operating Officer David Martin Afdahl acquired 4,400 common shares through a grant of restricted stock units. These RSUs carry no purchase price and represent a right to receive one share of common stock for each unit as they vest.
According to the award terms, 25% of the RSUs vest on July 1, 2026, with an additional 25% vesting each year for the next three years, as long as he remains in continuous service on each vesting date. Shares of common stock will be automatically withheld at each vesting to cover tax obligations. After this grant, he directly holds 157,302 common shares.
IBEX Ltd reported that Chief Sales/Marketing Officer Julie K. Casteel acquired 4,400 restricted stock units (RSUs) representing common shares. Each RSU converts into one common share as it vests. After this grant, she holds 121,194 common shares directly.
According to the award terms, 25% of the RSUs vest on July 1, 2026, with an additional 25% vesting on the same date in each of the following three years, provided she remains in continuous service. On each vesting date, shares of common stock will be automatically withheld to cover tax withholding obligations in a non‑discretionary transaction.
IBEX Ltd reported that Chief Sales and CS Officer Bruce Neil Dawson acquired 3,250 common shares through a grant of restricted stock units (RSUs) at a stated price of $0.00 per share. These RSUs convert into one common share each as they vest over time.
According to the award terms, 25% of the RSUs vest on July 1, 2026, with an additional 25% vesting annually over the following three years, so long as he remains continuously employed on each vesting date. After this grant, he directly holds 80,284 common shares. On each vesting date, a portion of shares will automatically be withheld by IBEX to cover tax withholding obligations in a non-discretionary transaction.
IBEX Ltd reported an equity award to its Chief Legal Officer, Christina Alice Trofimuk-O'Connor. She acquired 4,400 common shares in the form of restricted stock units (RSUs) at a price of $0.0000 per share, bringing her direct holdings to 35,735 common shares.
The RSUs vest over four years: 25% on July 1, 2026, with 25% vesting each year for the following three years, contingent on continued service. On each vesting date, IBEX will automatically withhold shares to cover tax obligations in a non-discretionary transaction.
Inson Paul Joseph reported acquisition or exercise transactions in this Form 4 filing.
IBEX Ltd reported that Chief People Officer Paul Joseph Inson received a grant of 4,000 restricted stock units, each representing a right to one common share. The RSUs vest 25% on July 1, 2026, then 25% annually over the next three years, subject to continued service. After this award, he holds 31,469 common shares directly. On each vesting date, a portion of shares will be automatically withheld to cover tax obligations.
IBEX Ltd insider Michael Joseph Darwal, the Chief AI & Digital Officer, reported an "other" type transaction involving 925 Common Shares at a reference price of $28.39 per share. After this event, his directly held stake is 41,260 Common Shares.
According to the footnote, these shares were transferred to a third party under a legal agreement related to a divorce dated December 29, 2025. The filing states that this transfer does not represent a discretionary transaction by the reporting person, indicating it was driven by personal legal obligations rather than an active investment decision.
IBEX Ltd director and Chief Executive Officer Robert Thomas Dechant reported an open-market sale of 6,000 Common Shares. The shares were sold at a weighted average price of $28.4588 per share in multiple trades. After this transaction, he directly owns 275,406 Common Shares.
The sale price reflects a weighted average of individual trades executed between $28.25 and $29.02 per share, and detailed trade breakdowns are available upon request as noted in the filing footnote.
IBEX Ltd Chief Executive Officer Robert Thomas Dechant reported selling a total of 12,000 Common Shares in two open-market transactions. He sold 6,000 shares on February 19, 2026 at a weighted average price of $29.7264 per share and another 6,000 shares on February 20, 2026 at a weighted average price of $29.3997 per share. After these sales, he continued to hold 281,406 Common Shares directly.
IBEX Ltd Chief Executive Officer and director Robert Thomas Dechant reported open-market sales of company common shares on two consecutive days. He sold 6,000 common shares on February 17 at a weighted average price of $29.6310 per share and another 6,000 shares on February 18 at a weighted average price of $29.9756 per share.
Both transactions were executed as multiple trades within stated price ranges, with detailed trade-level information available on request. Following these sales, Dechant directly owns 293,406 IBEX common shares.
IBEX Ltd’s Chief Sales/Marketing Officer, Julie K. Casteel, reported equity compensation activity in company common shares. On February 6, 2026, she acquired 97,126 restricted shares at $0 per share through a grant tied to a performance share award based on revenue and EBITDA targets.
On the same date, 8,649 shares were disposed of at $34.98 per share, representing shares withheld to cover taxes upon vesting. After these transactions, she directly held 116,794 common shares. One-third of the performance-based shares vested on February 6, 2026, with additional one-third tranches scheduled to vest on February 6, 2027 and February 6, 2028, subject to her continued service.
IBEX Ltd’s Chief Legal Officer, Christina Alice Trofimuk-O'Connor, reported equity compensation activity. On February 6, 2026, she acquired 19,557 common shares at $0 as a restricted stock award tied to an April 20, 2022 performance share grant based on revenue and EBITDA targets.
On the same date, 2,176 common shares were disposed of at $34.98 to cover taxes due at vesting. After these transactions, she directly held 31,335 IBEX common shares. One-third of the award vested on February 6, 2026, with additional thirds scheduled to vest on February 6, 2027 and February 6, 2028, subject to her continued service.
IBEX Ltd’s Chief Operating Officer, David Martin Afdahl, reported equity compensation activity. On February 6, 2026, he acquired 109,708 common shares at $0 as a restricted stock award tied to performance goals. On the same date, 13,917 shares were disposed of at $34.98 to cover taxes on the vesting. After these transactions, he directly owned 152,902 common shares. The award stems from an April 20, 2022 performance share grant that vests in three equal installments through 2028, contingent on continued service.